Sign up & Download
Sign in

Ophthalmology

In this subdiscipline: 35,356 papers

Discipline summary

Ophthalmology is the science of anatomy, physiology and pathology of the eye and vision. Ophthalmology is a medical specialty dealing with medical and surgical treatment of diseases of the eye and the periocular area. Ophthalmologic sub-specialties are retina, cornea, cataract, refractive surgery, glaucoma, oculoplastics, neuro-ophthalmology, uveitis and strabismus.

Popular papers

  1. PURPOSE: To describe a method to obtain images of the choroid using conventional spectral-domain (SD) optical coherence tomography (OCT) and to evaluate choroidal thickness measurements using these images. DESIGN: Observational case series. METHODS:…
  2. PURPOSE: To assess the long-term efficacy of a variable-dosing regimen with ranibizumab in the Prospective Optical Coherence Tomography (OCT) Imaging of Patients with Neovascular Age-Related Macular Degeneration (AMD) Treated with intraOcular…
  3. PURPOSE: To provide a review of commercially available spectral-domain optical coherence tomography (SD OCT) systems in clinical ophthalmology. DESIGN: Perspective. METHODS: Review of current manufacturer information, selected articles from the…
  4. PURPOSE: To assess efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular edema following branch retinal vein occlusion (BRVO). DESIGN: Prospective, randomized, sham injection-controlled,…
  5. The recent availability of genetic analyses has demonstrated the shortcomings of the current phenotypic method of corneal dystrophy classification. Abnormalities in different genes can cause a single phenotype, whereas different defects in a single…
  6. OBJECTIVE: To describe the natural history of branch retinal vein occlusion (BRVO) based on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal vein occlusion is the second most frequent major retinal vascular…
  7. PURPOSE: To test if fundus autofluorescence (FAF) patterns around geographic atrophy (GA) have an impact on GA progression rates over time in atrophic age-related macular degeneration (AMD). DESIGN: Prospective longitudinal multicenter natural…
  8. PURPOSE: To evaluate the efficacy and safety of ranibizumab administered monthly for three months and then quarterly in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). DESIGN: Phase…
  9. Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data.
  10. BACKGROUND: We compared ranibizumab-a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A-with photodynamic therapy with verteporfin in the treatment of predominantly classic…
  11. PURPOSE: To determine the prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) among patients with age-related macular degeneration (AMD). DESIGN: A prospective study with a nested case-control study of consecutive…
  12. Age-related macular degeneration (AMD) is the leading cause of irreversible severe visual loss in the United States in people over 50 years of age. The nonexudative stage includes hard drusen (associated with localized dysfunction of the retinal…

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Already have an account? Sign in

Active members

  1. Nils Loewen
    Assistant Professor
    Department of Ophthalmology and Visual Science, Yale University School of Medicine